Latest News and Press Releases
Want to stay updated on the latest news?
-
Robbins LLP is Investigating Allegations that Inovio Pharmaceuticals, Inc. (INO) Misled Investors Regarding Approval for its CELLECTRA Device
-
Robbins LLP is Investigating Allegations that Vistagen Therapeutics, Inc. (VTGN) Misled Investors Regarding the Viability of its Trial Study of Fasedieno
-
Robbins LLP is Investigating Allegations that Fermi Inc. (FRMI) Misled Investors Regarding its Business Prospects
-
Robbins LLP is Investigating Allegations that Oracle Corporation (ORCL) Misled Investors Regarding its AI Buildout
-
SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Civitas...
-
Robbins LLP is Investigating Allegations that Manhattan Associates, Inc. (MANH) Misled Investors Regarding its Growth Potential
-
Robbins LLP is Investigating Allegations that BigBear.ai Holdings, Inc. (BBAI) Has to Restate its Financial Statements
-
Robbins LLP is Investigating Allegations that Cerevel Therapeutics Holdings, Inc. (formerly CERE) Misled Investors Relating to the Company's October 16, 20
-
Robbins LLP is Investigating Allegations that Sana Biotechnology, Inc. (SANA) Misled Investors Regarding its Ability to Maintain Operations.
-
Robbins LLP is Investigating Allegations that Perpetua Resources Corp. (PPTA) Misled Investors Regarding the True Cost of its Stibnite Gold Project